Apoptotic Mechanisms in T47D and MCF-7 Human Breast Cancer Cells

Overview

Journal Br J Cancer

Specialty Oncology

Date 2002 Oct 10

PMID 12373608

Citations 56

Authors

L M Mooney

B L Brown

P R M Dobson

Affiliations

Soon will be listed here.

Abstract

To investigate the mechanisms underlying apoptosis in breast cancer cells, staurosporine was used as an apoptotic stimulus in the human breast cancer cell lines MCF-7 and T47D. Staurosporine induced dose and time dependent increases in DNA fragmentation which was abrogated by z-VAD-fmk. MCF-7 cells did not express caspase-3, suggesting that DNA fragmentation occurred in the absence of caspase-3 and that other caspases may be involved. Staurosporine induced DEVDase activity in T47D cells suggesting the involvement of caspase-3 and/or caspase-7, yet there was no DEVDase activity in MCF-7 cells, probably ruling out the involvement caspase-7. However, staurosporine induced the cleavage of pro-caspase-6 in MCF-7 cells, but not in T47D cells. Caspase dependent PARP cleavage was detected in MCF-7 cells at 3 h, whereas only partial PARP cleavage was detected in T47D cells and then only after 24 h. Moreover, staurosporine led to cytochrome c release at 2 h in MCF-7 cells and 6 h in T47D cells. In addition, a time dependent and caspase-independent reduction of the mitochondrial transmembrane potential was observed; which appeared to occur after the release of cytochrome c. Translocation of Bax from the cytosol to mitochondria was observed in both cell types, and this preceded cytochrome c release in both T47D and MCF-7 cells. Apoptotic events in both cell types differ temporally, involving activation of different caspases and mitochondrial changes.

Citing Articles

Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell Line.

Seane E, Nair S, Vandevoorde C, Bisio A, Joubert A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598379 PMC: 11597529. DOI: 10.3390/ph17111467.

Extended Synaptotagmins 1 and 2 Are Required for Store-Operated Calcium Entry, Cell Migration and Viability in Breast Cancer Cells.

Redondo P, Lopez J, Alvarado S, Jardin I, Nieto-Felipe J, Macias-Diaz A Cancers (Basel). 2024; 16(14).

PMID: 39061158 PMC: 11274662. DOI: 10.3390/cancers16142518.

5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) induces apoptosis in breast cancer cells through inhibiting of Mcl-1 expression.

Kuo Y, Lai T, Chang C, Hsieh H, Yang F, Hu M Sci Rep. 2023; 13(1):12621.

PMID: 37537243 PMC: 10400577. DOI: 10.1038/s41598-023-39340-x.

Galactosyl- and glucosylsphingosine induce lysosomal membrane permeabilization and cell death in cancer cells.

Stahl-Meyer K, Bilgin M, Holland L, Stahl-Meyer J, Kirkegaard T, Petersen N PLoS One. 2022; 17(11):e0277058.

PMID: 36409725 PMC: 9678304. DOI: 10.1371/journal.pone.0277058.

Cytochrome c: Using Biological Insight toward Engineering an Optimized Anticancer Biodrug.

Delinois L, De Leon-Velez O, Vazquez-Medina A, Velez-Cabrera A, Marrero-Sanchez A, Nieves-Escobar C Inorganics (Basel). 2022; 9(11).

PMID: 35978717 PMC: 9380692. DOI: 10.3390/inorganics9110083.

References

Reed J . Bcl-2 family proteins. Oncogene. 1999; 17(25):3225-36. DOI: 10.1038/sj.onc.1202591. View

Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H . Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene. 1996; 13(1):21-9. View

Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A . Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 1997; 57(1):62-7. View

Tudor G, Aguilera A, Halverson D, Laing N, Sausville E . Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ. 2000; 7(6):574-86. DOI: 10.1038/sj.cdd.4400688. View

Zheng T, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson D . Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med. 2000; 6(11):1241-7. DOI: 10.1038/81343. View

Saunders D, Lawrence W, Christensen C, Wappler N, Ruan H, Deppe G . Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int J Cancer. 1997; 70(2):214-20. DOI: 10.1002/(sici)1097-0215(19970117)70:2<214::aid-ijc13>3.0.co;2-i. View

Hishikawa K, Oemar B, Tanner F, Nakaki T, Luscher T, Fujii T . Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem. 1999; 274(52):37461-6. DOI: 10.1074/jbc.274.52.37461. View

Bossy-Wetzel E, Newmeyer D, Green D . Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 1998; 17(1):37-49. PMC: 1170356. DOI: 10.1093/emboj/17.1.37. View

Yang J, Liu X, Bhalla K, Kim C, Ibrado A, Cai J . Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997; 275(5303):1129-32. DOI: 10.1126/science.275.5303.1129. View

10.

Wolf B, Schuler M, Echeverri F, Green D . Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem. 1999; 274(43):30651-6. DOI: 10.1074/jbc.274.43.30651. View

11.

Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S . A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998; 391(6662):43-50. DOI: 10.1038/34112. View

12.

Woo M, Hakem R, Soengas M, Duncan G, Shahinian A, Kagi D . Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998; 12(6):806-19. PMC: 316633. DOI: 10.1101/gad.12.6.806. View

13.

Hsu Y, Wolter K, Youle R . Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A. 1997; 94(8):3668-72. PMC: 20498. DOI: 10.1073/pnas.94.8.3668. View

14.

Osborne C, Hobbs K, Trent J . Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987; 9(2):111-21. DOI: 10.1007/BF01807363. View

15.

Liu X, Zou H, Widlak P, GARRARD W, Wang X . Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. J Biol Chem. 1999; 274(20):13836-40. DOI: 10.1074/jbc.274.20.13836. View

16.

Liu X, Kim C, Yang J, Jemmerson R, Wang X . Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996; 86(1):147-57. DOI: 10.1016/s0092-8674(00)80085-9. View

17.

Jacobsen M, Weil M, Raff M . Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol. 1996; 133(5):1041-51. PMC: 2120856. DOI: 10.1083/jcb.133.5.1041. View

18.

Chittenden T, Harrington E, OConnor R, Flemington C, Lutz R, Evan G . Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 1995; 374(6524):733-6. DOI: 10.1038/374733a0. View

19.

Janicke R, Ng P, Sprengart M, Porter A . Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem. 1998; 273(25):15540-5. DOI: 10.1074/jbc.273.25.15540. View

20.

Zhang H, Heim J, Meyhack B . Redistribution of Bax from cytosol to membranes is induced by apoptotic stimuli and is an early step in the apoptotic pathway. Biochem Biophys Res Commun. 1998; 251(2):454-9. DOI: 10.1006/bbrc.1998.9485. View